An observational study in COPD Exacerbation, sponsored by Universidad Autonoma de Madrid. Completed at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-12-06.
Sponsored by Universidad Autonoma de Madrid · Observational
identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.
Universidad Autonoma de Madrid is the lead sponsor of 48 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients from Primary Health Care, Elderly care homes, and HULP
Exclusion Criteria:
Patients over 65 years old diagnosed with COPD in GOLD II state or higher who uses Breath Detect Platform for monitoring their respiratory health status.
Diagnostic Test: Breath Detect Platform
Use of the Breath Detect platform for respiratory health monitoring.
Number of hospital admissions due to exacerbations
Time frame: 24 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Autonoma de Madrid